Teva Pharmaceutical Industries Ltd

NYSE : TEVA
ISR·Healthcare·Drug Manufacturers·ADR
$41.50
+0.25 (+0.68%)Oct 16 close
Market Cap
$48.33B
Enterprise Value
$61.56B
P/E (TTM)
60.45
P/B
5.44
Net Cash / (Debt)
−$13.22B
52-Week Range
$19 — $42
5-Year Range
$6.86 — $42
Avg Volume (3M)
5.77M

Curated managers

6 of 57 hold Teva Pharmaceutical Industries Ltd · holdings at Jun 30, 2026

Manager% of bookChange
Glenview Capital Management, LLC
Larry Robbins · Chief Investment Officer
3.44%Reduced-1.6M
Greenlight Capital (DME Capital Management, LP)
David Einhorn · President
2.50%Reduced-24.7K
Bridgewater Associates, LP
Ray Dalio · Founder (relinquished control of the firm in 2022) (historical)
0.18%Added+198.3K
ARK Investment Management LLC
Cathie Wood · Chief Executive Officer, Chief Investment Officer
0.02%Added+374
Baron Capital Group (BAMCO, Inc.)
Ron Baron · Founder, Chief Executive Officer and Portfolio Manager
0.01%Added+9.0K
Duquesne Family Office LLC—Reduced-1.8M